Table 1.

Baseline clinical characteristics among patients treated with drug eluting stent(s) stratified by the need for subsequent target vessel revascularization

Variable	Total number	No TVR %	TVR %	P value
Patients	2691	93.2	6.8
Age over 65				0.003
No	1463	91.9	8.1
Yes	1228	94.8	5.2
Female				0.11
No	1805	93.7	6.3
Yes	886	92.1	7.9
Prior Percutaneous Procedure(s)				<.0001
No	1805	94.5	5.5
Yes	886	79.9	20.1
Prior brachytherapy				<.0001
No	2657	93.4	6.6
Yes	34	76.5	23.5
Prior stent				<.0001
No	1944	94.4	5.6
Yes	747	90.1	9.9
History of in-stent restenosis				0.002
No	583	91.8	8.2
Yes	165	83.6	16.4
Prior coronary bypass				<.0001
No	2193	94.0	6.0
Yes	498	70.0	30.0
Prior myocardial infarction				0.04
No	1984	93.8	6.3
Yes	635	91.3	8.7
Diabetes				<.0001
No	1775	94.6	5.4
Yes	913	90.5	9.5
History of congestive heart failure				0.33
No	2386	93.4	6.6
Yes	255	91.8	8.2
Hypertension				0.06
No	588	94.9	5.1
Yes	2079	92.7	7.3
Hypercholesterolemia				0.03
No	559	95.2	4.8
Yes	2059	92.6	7.4
Smoking				0.0003
Current	626	93.9	6.1
Never/Former	1907	85.6	14.4
Cerebrovascular disease				0.83
No	2491	93.2	6.8
Yes	195	92.8	7.2
Chronic kidney disease				0.13
No	2433	93.4	6.6
Yes	253	90.9	9.1
Peripheral vascular disease				0.08
No	2458	93.4	6.6
Yes	228	90.4	9.6
Pulmonary disease				0.69
No	2459	93.1	6.9
Yes	227	93.8	6.2

TVR- target vessel revascularization